The gene therapy sub-industry focuses on treatments that modify genes to cure or treat diseases. In 2024, significant breakthroughs are being made in treating genetic disorders, driving market growth.
Cautious investment is suggested. There may be selective opportunities for turnaround specialists or those with high risk tolerance.